Erlotinib Active Not Recruiting Phase 1 / 2 Trials for Adenocarcinoma of the Pancreas / Malignant Neoplasm of Pancreas Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT02154737Gemcitabine and Pulse Dose Erlotinib in Second Line Treatment of Advanced Pancreatic Cancer